Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page
- Check4 days agoChange DetectedThe page revision has been updated to v3.6.5, replacing v3.6.4. This reflects an updated document state rather than changes to the study details or overall content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA publication citation in the Publications section was updated to reflect a 2026 July version with a DOI, replacing the earlier print/online-ahead-of-print entry. This is a bibliographic update rather than a change to study data or conduct.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small update to the study record.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays revision v3.6.2, replacing v3.6.0, indicating a small maintenance update to the page's version tag without altering study content.SummaryDifference0.1%

- Check61 days agoChange DetectedRecruitment status now shows the study is not currently enrolling participants. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page revision note confirms the latest version.SummaryDifference0.4%

- Check69 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, indicating a newer version of the page. No study data or descriptions are altered.SummaryDifference0.0%

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.